ALPL Antibody Blocking peptide
ALPL Antibody Blocking peptide
Product Specifications
Product Name Alternative
Alkaline phosphatase, tissue-nonspecific isozyme, AP-TNAP, TNSALP, Alkaline phosphatase liver/bone/kidney isozyme, ALPL
UniProt
P05186
Field of Research
Signal Transduction
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence used to generate the antibody orb1935523 was selected from the Center region of human ALPL. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
138358-AP 100 µL
SLC25A16 (Graves Disease Carrier Protein, GDC, Graves Disease Autoantigen, GDA, Mitochondrial Solute Carrier Protein Homolog, Solute Carrier Family 25 Member 16, GDA) (AP) discontinued
Sign In for Pricing
View Details 
041065-Biotin 200 µL
RIT2, NT (RIT2, RIN, ROC2, GTP-binding protein Rit2, Ras-like protein expressed in neurons, Ras-like without CAAX protein 2) (Biotin) discontinued
Sign In for Pricing
View Details MBS1228795-01 0.02 mg (E-Coli)
Recombinant Plasmodium falciparum Reticulocyte-binding protein PFD0110w (PFD0110w), partial
Sign In for Pricing
View Details